Salinda, Felix B.
HRN: 21-40-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2022
CEFTAZIDIME 1GM (VIAL)
05/27/2022
06/02/2022
IV
1g
Q8H
CAP-MR
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes